EBOS issues new performance rights under long-term incentive plan

EBOS Group Limited ( (AU:EBO) ) has shared an announcement.

EBOS Group Limited has issued 12,424 new Performance Rights under its Performance Rights Plan, representing 0.00868% of the Performance Rights on issue, bringing the total to 1,443,114. The rights, granted at no cost and carrying no dividends before vesting, entitle holders to one fully paid ordinary share or cash equivalent per right, subject to financial performance and employment conditions tested over the period from 1 July 2026 to 30 June 2029.

The issuance, approved by directors’ resolution, underscores EBOS’s continued use of long-term incentive structures to retain key staff and tie rewards to multi-year performance outcomes. Any shares issued on vesting will rank equally with existing ordinary shares, meaning the plan may marginally dilute existing holders over time while aiming to strengthen management alignment with shareholder interests.

The most recent analyst rating on (AU:EBO) stock is a Buy with a A$29.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.

More about EBOS Group Limited

EBOS Group Limited is a listed company operating in the healthcare and pharmaceutical distribution sector, with its ordinary shares traded under the ticker EBO. The company uses performance-based equity incentives, such as Performance Rights plans, to align employee remuneration with long-term financial performance and shareholder value.

Average Trading Volume: 155,102

Technical Sentiment Signal: Sell

Current Market Cap: A$3.73B

For an in-depth examination of EBO stock, go to TipRanks’ Overview page.